[PDF][PDF] TGF-β-miR-34a-CCL22 signaling-induced Treg cell recruitment promotes venous metastases of HBV-positive hepatocellular carcinoma
Portal vein tumor thrombus (PVTT) is strongly correlated to a poor prognosis for patients
with hepatocellular carcinoma (HCC). In this study, we uncovered a causative link between …
with hepatocellular carcinoma (HCC). In this study, we uncovered a causative link between …
[HTML][HTML] Serum microRNAs as biomarkers for hepatocellular carcinoma in Chinese patients with chronic hepatitis B virus infection
P Qi, S Cheng, H Wang, N Li, Y Chen, C Gao - PloS one, 2011 - journals.plos.org
Background MicroRNAs (miRNAs) have been shown to anticipate great cancer diagnostic
potential. Recently, circulating miRNAs have been reported as promising biomarkers for …
potential. Recently, circulating miRNAs have been reported as promising biomarkers for …
Surgical treatment of hepatocellular carcinoma with portal vein tumor thrombus
…, WX Guo, J Xue, WY Lau, MC Wu, SQ Cheng - Annals of surgical …, 2010 - Springer
Background The role of liver resection in patients with hepatocellular carcinoma (HCC)
accompanying with portal vein tumor thrombus (PVTT) remains controversial. This article aimed …
accompanying with portal vein tumor thrombus (PVTT) remains controversial. This article aimed …
A new classification for hepatocellular carcinoma with portal vein tumor thrombus
…, WX Guo, J Xue, WY Lau, MC Wu, SQ Cheng - Journal of hepato-biliary …, 2011 - Springer
Background/purpose We aimed to correlate the survival of patients with hepatocellular
carcinoma (HCC) with macroscopic portal vein tumor thrombus (PVTT) who underwent partial …
carcinoma (HCC) with macroscopic portal vein tumor thrombus (PVTT) who underwent partial …
Treatment for hepatocellular carcinoma with portal vein tumor thrombosis: the emerging role for radioembolization using yttrium-90
Background/Purpose: Patients with hepatocellular carcinoma (HCC) with portal vein tumor
thrombosis (PVTT) have an extremely poor prognosis and relatively few treatment options. …
thrombosis (PVTT) have an extremely poor prognosis and relatively few treatment options. …
Postoperative adjuvant transcatheter arterial chemoembolization after R0 hepatectomy improves outcomes of patients who have hepatocellular carcinoma with …
…, J Shi, WM Cong, MC Wu, WY Lau, SQ Cheng - Annals of surgical …, 2016 - Springer
Background Microvascular invasion (MiVI) is a major risk factor of survival outcomes after
curative resection for patients with hepatocellular carcinoma (HCC). This study aimed to …
curative resection for patients with hepatocellular carcinoma (HCC). This study aimed to …
Management of patients with hepatocellular carcinoma and portal vein tumour thrombosis: comparing east and west
…, DC Madoff, JC Davidson, X Qi, SQ Cheng… - The lancet …, 2019 - thelancet.com
Portal vein tumour thrombosis is common among patients with advanced hepatocellular
carcinoma. Tremendous differences exist in the management of hepatocellular carcinoma with …
carcinoma. Tremendous differences exist in the management of hepatocellular carcinoma with …
[HTML][HTML] Multimodality treatment for hepatocellular carcinoma with portal vein tumor thrombus: a large-scale, multicenter, propensity mathching score analysis
…, YF Yang, WM Cong, MC Wu, WY Lau, SQ Cheng - Medicine, 2016 - journals.lww.com
… In this study, we analyzed the characteristics of Chinese HCC patients with PVTT and
compared the effectiveness of ST, TACE, TACE combined with sorafenib (TACE-Sor), and TACE …
compared the effectiveness of ST, TACE, TACE combined with sorafenib (TACE-Sor), and TACE …
[PDF][PDF] An eastern hepatobiliary surgery hospital/portal vein tumor thrombus scoring system as an aid to decision making on hepatectomy for hepatocellular carcinoma …
…, J Shi, D Xie, MC Wu, W Yee Lau, SQ Cheng - …, 2019 - Wiley Online Library
Portal vein tumor thrombus (PVTT) is a significant poor prognostic factor for hepatocellular
carcinoma (HCC). Patients with PVTT limited to a first‐order branch of the main portal vein (…
carcinoma (HCC). Patients with PVTT limited to a first‐order branch of the main portal vein (…
[PDF][PDF] Sorafenib suppresses postsurgical recurrence and metastasis of hepatocellular carcinoma in an orthotopic mouse model
…, N Li, MC Wu, HY Wang, XF Wang, SQ Cheng… - …, 2011 - Wiley Online Library
Surgical resection is the first‐line treatment for hepatocellular carcinoma (HCC) patients with
well‐preserved liver function. Nevertheless, the rate of postoperative recurrence at 5 years …
well‐preserved liver function. Nevertheless, the rate of postoperative recurrence at 5 years …